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Abstract
Staphylococcus aureus harbours several iron acquisition systems,
allowing for survival within the iron-restricted host environment. Five such
systems have been identified in S. aureus; it is unknown why S. aureus
maintains so many of these systems. Studies have shown that some iron
transport proteins might be differentially expressed in different organs in vivo.
The purpose of this study was to construct an in vivo expression technology
(IVET) system to identify temporal expression patterns of S. aureus iron transport
systems. An IVET utilizing the CrelloxP recombination system was constructed
for use in S. aureus. Using genome-integrated and multi-copy ere constructs
driven by the S. aureus fhuCBG promoter, resolution of an in vitro reporter
cassette was determined. Although fhuCBG driven ere expression was confirmed
using the multi-copy ere constructs, no detectable Cre was expressed by
genome-integrated cre constructs.
Keywords
Staphylococcus aureus, RIVET, Cre//oxP recombination,
iron-regulated promoters, iron transport
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Chapter 1: Introduction

1

1.1 The Staphylococci
The Staphylococci are a group of Gram-positive, facultative anaerobic
bacteria, commonly part of the skin and mucosal membrane flora of humans and
other mammals (65). Staphylococci are generally split into two groups, based on
their ability to produce the clot forming enzyme coagulase. The coagulasenegative Staphylococcus (CoNS) group is comprised of staphylococcal species
such as S. epidermidis and S. saprophyticus, while the coagulase-positive
Staphylococcus (CoPS) group is comprised of staphylococcal species such as S.
aureus.
1.1.1

Staphylococcus aureus

Although several species of staphylococci are capable of causing disease
in humans, particularly S. epidermidis (84), S. aureus has received the most
attention as strains have been implicated in a variety of nosocomial- and
community-associated infections (61, 76, 108). S. aureus is capable of causing
such a variety of diseases due to the extensive array of virulence factors it
harbours (Table 1). Indeed, S. aureus has been implicated as the causative
agent of simple skin and soft tissue infections such as impetigo (7), as well as
severe invasive diseases such as necrotizing pneumonia (73). More recently, a
rise in antibiotic resistant strains of S. aureus in both the hospital and community
setting have resulted in an increased frequency of difficult to treat S. aureus
infections. Strains of methicillin resistant S. aureus (MRSA), known for their
complete resistance to the beta-lactam class of antibiotics, have been frequently
associated with such infections, as several MRSA strains have obtained
additional genetic elements providing resistance to a variety of other antibiotic
2

Table 1: A sampling of virulence determinants of S. aureus
Virulence Class
Adhesins
spa

Function

Reference

Binds to antibody Fc region

112

cna

Collagen-binding protein

85

clfA, clfB

Fibrinogen-binding proteins

Superantigens
tst, seq, sek

Membrane-damaging
toxins
PSMa, PSM(3
hla
Host Defence Evasion
crtM

cap

Overstimulation of T-cells,
extensive cytokine release

70, 77

8, 31

Neutrophil lysis

118

Pore-forming toxin

13

Antioxidant; resistance to
neutrophil killing

58

Capsule modulation;
Resistance to leukocyte
opsonophagocytosis

113

3

classes (29). Due to pathogenic strains such as MRSA, new therapeutic
strategies are needed in order to complement, or even replace the current
antibiotic-dependent strategies used to treat S. aureus and other pathogens. One
such strategy involves the interruption of bacterial nutrient acquisition systems
critical for the survival of the pathogen. Although many bacterial species
(including S. aureus) harbour a variety of different nutrient acquisition systems,
this thesis will specifically focus on the importance of iron, and bacterial iron
acquisition systems.
1.2 Iron: A necessary bacterial nutrient
With the exception of Borrelia burgdorferi and some lactobacilli species,
iron is an essential nutrient required for bacterial growth (4, 11, 48, 90, 99).
However, under physiological conditions, the availability of free iron for use by
bacteria is severely restricted. Indeed, in an aerobic, neutral pH environment,
concentrations of iron are restricted to a concentration of 10'18 M, as iron forms
insoluble iron(lll) hydroxides in such an environment (14, 24). In addition, iron
availability is further restricted for mammalian bacterial pathogens due to the
presence of host iron sequestering proteins, such as transferrin and lactoferrin,
reducing free iron concentrations to as little as 10'24 M (94). In order to survive in
such iron restricted environments, a variety of Gram-positive and Gram-negative
bacteria have developed specialized iron acquisition systems, some of which will
be described below, allowing them to utilize free iron and even ‘steal’ it from host
iron sequestering proteins.
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1.3 Bacterial iron acquisition systems
Although there are a variety of iron acquisition systems used by Gram
positive and Gram-negative bacteria, for the purposes of this thesis, only the
siderophore-mediated systems will be described in depth here.
1.3.1

Siderophores

Siderophores are small, highly electronegative low molecular weight
molecules with high affinity for free iron(lll), which are then brought into the cell
through a cognate receptor and transporter. Siderophores are generally
classified into one of three groups, each of which are distinguished by the moiety
used to coordinate the iron(lll) atom (24). Siderophores of the hydroxamate
group have hydroxamic acid moieties in which the carboyl and aminohydoxyl
groups each occupy an iron coordination site. Catecholates utilize the adjacent
hydroxyl groups of catechol moieties in order to coordinate iron. Finally,
polycarboxylate motifs coordinate iron(lll) atoms using either carboxylic acid
moieties (17), or a-hydroxy-carboxylates (1). Interestingly, a variety of
siderophores have been identified which utilize combinations of the above three
groups (9, 16, 87). Some representative siderophores are depicted in Figure 1.
One of the more intriguing aspects of siderophores is that several
siderophores can be used by more than one bacterial species, so long as they
express the necessary transport apparatus. This has been shown to occur in a
variety of bacteria, such as S. aureus (109), E. coli (119) and Listeria
monocytogenes (22).

5
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Figure 1: Sample siderophores representing (A) each of the three siderophore
groups: Catecolates (enterobactin), hydroxymates (coprogen), polycarboxylates
(rhizoferrin), as well a hybrid siderophore (aerobactin: a hydroxamatecarboxylate hybrid), and (B) Siderophores produced by S. aureus. Siderophore
structures were adapted from (6).
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1.3.2

Iron uptake ABC transporters

ATP-binding cassette (ABC) transporters are transmembrane proteins
which use the energy created by the hydrolysis of adenosine triphosphate (ATP)
in order to transport a variety of substrates across cell membranes; many have
been shown to be essential for cell viability, as well as bacterial virulence (27).
ABC transporters can be used to import, as well as export, substrates across the
cell membrane; iron uptake ABC transporters act as importers and consist of a
transmembrane permease, an ATP-binding cassette (ABC) protein and a
periplasmic binding protein (PBP). The PBP is of particular importance, as it
associates with periplasmic iron(lll)-siderophore complexes, which are then
taken to the appropriate ABC transporter. It is important to note that, due to a
lack of an outer membrane in Gram-positive bacteria, there are slight differences
between ABC transporters of Gram-positive and Gram-negative bacteria (Figure
2). Gram-positive iron uptake ABC transporters utilize an iron(lll)-siderophore
binding protein anchored to the cytoplasmic membrane. In general, these
proteins have a similar overall protein fold as the Gram-negative PBPs; the
binding protein acts similarly to the PBP receptor found in Gram-negative iron
uptake ABC transporters (24).
1.4 Staphylococcus aureus iron acquisition systems
S. aureus harbours an array of iron scavenging systems, allowing the
pathogen to survive in the harsh, iron restricted host environment (Table 2).
These iron acquisition systems are regulated by the ferric uptake repressor (Fur).

8
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Figure 2: Cartoon models of a prototypical Gram-positive (A) and Gram-negative
(B) ABC intake transporter. While the Gram-positive binding protein (BP) is
tethered to the membrane by a lipid anchor, the periplasmic binding protein
(PBP) is free in solution. Both systems utilize a permease which transports the
ligand across the cellular membrane. An ATPase provides energy for the
transport process. Note that various accessory proteins have been left out of the
Gram-negative ABC transporter structure to simplify the image. OMR: Outer
membrane receptor.
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Table 2: S. aureus genes associated with iron acquisition
Gene(s)

Function

Reference
101

fhuCBG

Fe3+-hydroxamate ABC transporter

fhuD1, fhuD2

Fe3+-hydroxamate lipoprotein receptor

htsABC

Staphyloferrin A ABC transporter;
heme transfer (?)

5, 106

sirABC

Staphyloferrin B ABC transporter

25

sstABCD

Siderophore ABC transporter (?)

74

sfaABCD

Staphyloferrin A biosynthesis

21

sbnABCDEFGHI

Staphyloferrin B biosynthesis

26

isdA, isdC

Fieme binding and transfer

isdB, isdH

Flemoglobin/haptoglobin binding

isdDEF

Fieme transport membrane proteins

isdG, isdl

Fieme degradation

il

102, 103

38, 64, 69
33
38, 89
105

What follows is a brief analysis of these iron acquisition systems (see Figure 3),
as well as how they are regulated by Fur.
1.4.1

Regulation of the iron acquisition systems in S. aureus

Indeed, S. aureus and many other microbes have evolved mechanisms
capable of controlling iron uptake. However, it is equally important that these
systems are only activated when necessary; too much iron can result in a toxic
effect to the bacterial cells (37). All S. aureus iron acquisition systems are
regulated by a negative repressor protein known as the ferric uptake regulator, or
Fur. While Fur is found in an abundant number of bacterial species (92), only S.
aureus Fur mediated regulation will be discussed here, and is illustrated in Figure
3.
The S. aureus Fur protein, combined with Fe2+, the Fur co-repressor, acts
to repress the S. aureus iron uptake systems when environmental iron
concentrations are sufficient for the bacteria to thrive. Repression occurs through
the interference of transcription of the iron-regulated genes. The Fur-Fe2+
complex binds to a specific sequence of DNA, the Fur box, a 19 bp palindromic
sequence (GATAATGATAATCATTATC (28)) located within the promoter region.
However, if iron concentrations become limited, then there is a reduced level of
Fe2+that can complexed with the Fur protein, resulting in the Fur protein being
unable to bind to the Fur box, resulting in de-repression of the iron regulated
genes.
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Figure 3: Transcriptional control of iron-regulated genes by the Fur protein in S.
aureus. In the presence of high concentrations of iron, the Fur protein
(represented here as solid squares) is associated with ferrous iron, its co
repressor. This Fur-Fe2+ complex has a significantly higher DNA binding capacity
than that of the Fur protein alone, thereby allowing the Fur-Fe2+ complex to bind
to the Fur box sequence, resulting in repression of the iron-regulated gene (Top).
However, if iron is in limited quantities in the environment, there is too little of the
co-repressor to bind to the Fur protein, reducing its ability to bind to the Fur box,
resulting in derepression of the iron-regulated gene (bottom).

Iron Rich Environment
Iron-regulated gene is repressed by Fur
—jlron-regulated geneV

Iron restricted Environment
Derepression of Iron-regulated gene
{Iron-regulated gene
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1.4.2

Staphylococcus aureus siderophore iron uptake systems

To date, three siderophores have been identified in S. aureus
supernatants: staphyloferrin A (53), staphyloferrin B (32), and aureochelin (23).
The genetic loci and biosynthetic pathways of the polycarboxylates staphyloferrin
A and B have been recently identified (Figure 4) (19, 21).
The Staphyloferrin A sfa locus is comprised of the sfaABC operon, and a
divergently transcribed sfaD. All four genes are known to be transcriptionally
controlled by Fur in S. aureus (5), as a consensus Fur box is positioned
intergenically between sfaA and sfaD. Interestingly, deletion of sfa does not
result in a significant defect in bacterial growth in mammalian serum (5).
However, when combined with a staphyloferrin B deletion mutant, bacterial
growth in mammalian serum was severely attenuated. Bacterial growth was
restored when the sfa genes from S. aureus were cloned into a complementation
vector and introduced into the sbn-sfa double mutant (5). The observation that
staphyloferrin A-deficient strains of S. aureus do not suffer from a reduction in
bacterial growth unless combined with a staphyloferrin B deficiency indicates that
staphyloferrin A may not play a significant role in iron extraction from transferrin,
the primary iron substrate in serum. However, a previous study reported that
staphyloferrin A was capable of leaching iron from human transferrin (72);
Beasley and Heinrichs have postulated that this may have been caused by the
use of a staphyloferrin A concentration which far exceeds that which is typically
seen in S. aureus supernatants, resulting in transferrin iron extraction by
staphyloferrin A (6).
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Figure 4: Genetic loci of S. aureus involved in iron acquisition. The sbn-sir and
sfa-hts loci are responsible for the biosynthesis and transport of staphyloferrin B,
and staphyloferrin A, respectively. The fhuCBG-D1-D2 locus is responsible for
the transport of hydroxamate siderophores, and the isd locus encodes
components of the heme-scavenging iron-regulated surface determinant system.
Finally, the iron-regulated sstABCD operon encodes for an ABC transporter,
however its substrate has yet to be identified.
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The staphyloferrin B siderophore biosynthesis gene cluster, known as sbn,
is comprised of a nine gene iron-regulated operon (26). Inactivation of the sbn
operon in S. aureus results in attenuated growth in mammalian serum. However,
S. aureus growth levels are nearly restored to wild-type levels with prolonged
incubation; this may be due to the production of staphyloferrin A (5).
1.4.3

Staphylococcus aureus iron(lll)-siderophore transport

S. aureus uses an assortment of iron-regulated ABC transporters in order
to bring free iron through its cellular membrane and into the cell. Five ironregulated ABC transporters, depicted in Figure 5, have been identified in S.
aureus: the ferric hydroxamate uptake (Fhu) system (101), the staphylococcal
iron regulated (Sir) system (25), the heme iron transporter (Hts) (106), the
staphylococcal siderophore transporter (Sst) (74), and the iron-regulated surface
determinant (Isd) heme transporter (69).
1.4.3.1 Ferric hydroxamate uptake system
The ferric hydroxamate uptake (Fhu) system is utilized in the uptake of
iron(lll)-hydroxamate siderophores. Interestingly, S. aureus does not produce
hydroxamate siderophores; the Fhu system allows S. aureus to utilize exogenous
hydroxamate siderophores (101). The iron and Fur-regulated genetic elements of
the Fhu system, shown in Figure 4, encode permease components (FhuB and
FhuG), an ATPase (FhuC), and dual binding proteins (FhuD1, FhuD2) (103).
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Figure 5: A simplified diagram of five iron transport system in S. aureus. Arrows
in the Isd system represent the paths that heme can take through the system
before it is transported across the membrane and degraded. metHB:
methemoglobin; Hp-hp: Haptoglobin-hemoglobin; SA-Fe: staphyloferrin A-iron
complex; SB-Fe: staphyloferrin B-iron complex; Hyd-Fe: Hydroxamate-iron
complex.
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1.4.3.2 Staphylococcal-iron regulated transport system
The staphylococcal iron regulated (Sir) transport system acts as the ABC
transporter for the uptake of staphyloferrin B complexed with iron. The three
gene sirABC operon, which encodes a binding protein (SirA) (42) and permeases
(SirB, SirC), is divergently transcribed from the sbn operon (Figure 4).
Interestingly, the iron and Fur-regulated sirABC operon does not encode an
ATPase. Studies from our lab have provided evidence that FhuC from the Fhu
transport system is utilized as the ATPase required for staphyloferrin B uptake
(109).
1.4.3.3 Heme iron transport system
Early studies by Skaar et al. originally implicated the heme iron transport
system (Hts) in heme transport (106). This study identified the htsABC operon,
and through the inactivation of htsB and htsC (each encoding permease
components), indirectly showed that the iron preference of S. aureus changed
from heme to transferrin (106). However, direct involvement of Hts in heme
transport has yet to be ascertained. Interestingly, a recent study demonstrated
that the Hts transporter is involved in S. aureus staphyloferrin A uptake (5). HtsA
has been identified as part of the class III family of binding proteins, and has
been shown to bind to the iron-staphyloferrin A complex using a highly positively
charged binding pocket (40). This pocket contains a patch of six arginine
residues which make contact with the siderophore, holding it in place within the
pocket. Furthermore, a deletion of the htsABC operon resulted in no uptake of
staphyloferrin A (5). It should be noted that similar to the sirABC operon, no
21

ATPase-encoding gene is found in the htsABC operon. Evidence suggests that
the FhuC ATPase is once again used in staphyloferrin A uptake (5).
1.4.3.4 Iron-regulated surface determinant heme transporter
The iron-regulated surface determinant (Isd) heme transporter is one part
of the heme-scavenging Isd system (Figure 5). The S. aureus genome contains
nine iron-regulated isd genes (Table 2; Figure 4) which encode nine proteins
involved in heme uptake in the isd system. Two additional proteins, sortase A
(SrtA) and sortase B (SrtB) are also critical components of the isd system. The
IsdA, IsdB, IsdC and IsdH proteins are heme surface receptor proteins anchored
to the cell wall (33, 69). With the exception of IsdC, these surface receptors are
anchored to the peptidoglycan cross-bridges of the cell wall by SrtA; IsdC is
anchored by SrtB (69). While IsdA and IsdC are buried in the cell wall, IsdB and
IsdH are exposed to the extracellular milieu, allowing them to bind to heme from
methemoglobin or haptoglobin-hemoglobin (32, 69). Heme can then either be
transferred bidirectionally between IsdB and IsdH (75), or from either IsdB or
IsdH to IsdA, then directly to IsdC. From IsdC, heme is transferred to the Isd ABC
transporter. Once heme is bound to IsdC, it is transferred to IsdE, prior to
passage through the Isd ABC transporter (IsdF). The heme is then taken through
the permease (IsdF), and into the cell. As with the Sir and Hts transporters, there
is no obvious ATPase encoded by the isd locus. Grigg et at. has suggested that
the Fhu system ATPase, FhuC, may be used by the Isd ABC transporter (39).
Once inside the cell, heme is then degraded by IsdG and Isdl (108), releasing
iron which can then be used as a nutrient by the cell.
22

1.4.3.5 Staphylococcal siderophore transporter
To date, there is limited understanding of the staphylococcal siderophore
transporter (Sst). The sstABCD operon encodes two putative cytoplasmic
membrane proteins (SstA and SstB) believed to form a permease, an ATPase
(SstC), and a receptor-binding lipoprotein (SstD) (74). The substrate transported
by Sst has not yet been elucidated. However, it is believed that the Sst
transporter is involved in iron acquisition in some manner, as the sstABCD
operon is iron and Fur regulated (74).
1.5

Expression of iron acquisition systems in Staphylococcus aureus
While extensive studies of S. aureus iron acquisition systems have

resulted in the elucidation of a considerable number of iron-regulated genetic
elements, little is known about when these genes are expressed in vivo. For
example, it is unknown why S. aureus carries so many different iron acquisition
systems in its genome; a recent study by Pishchany et al. showed that IsdA and
IsdB are differentially expressed in the heart and liver in mice (88). Thus, it could
be hypothesized that S. aureus may be expressing these different iron
acquisition systems in specific organs in order to survive, or even that different
systems are expressed at different time points throughout the course of an
infection. Typical in vitro procedures are unable to ascertain such data; thus, in
order to determine what iron acquisition systems are being expressed (or when
they are being expressed) in vivo, a system capable of accurately identifying
genes expressed in vivo must be used.
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1.6 Identifying genes expressed in vivo
An inherent issue with in vitro studies is that, despite the variety of growth
media used to culture bacteria and mimic in vivo growth conditions, they are
unable to completely capture the complex nature or cellular interactions of the
host environment. Thus, it is possible that select genes that are shown to be
active in the in vitro environment may not necessarily be active in vivo, or vice
versa (107). This is of particular importance when studying the role(s) of
virulence determinants required for a pathogen to survive during the course of an
infection, the ever changing environment of the host to combat the pathogen may
result in the different virulence determinants being turned on or off over the
course of the infection, something that may not be readily identified using in vitro
studies (107). In 1987, Osbourne et al. developed a system that would later
become known as in vivo expression technology (IVET), which was designed so
as to overcome such problems by selecting for bacterial genes that are highly
expressed in the host, but not in laboratory media (82). Since its inception, IVET
and similar techniques have been used to identify an assortment of in vivo
induced (ivi) genes, in a variety of microorganisms. Here, several IVET strategies
will be described.
1.6.1 In vivo expression technology
In vivo expression technology (IVET) is a promoter trap assay capable of
monitoring promoter activity through the use of a selectable marker. Although an
IVET system was originally designed by Osbourne et al. to identify Xanthomonas
campestris virulence genes induced in vivo during an infection with its host the
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turnip (82), the term in vivo expression technology was not coined until 1993 by
Mahan et al., where the system was adapted to a murine model to identify
Salmonella, typhimurium ivi genes (66). The IVET promoter trap works by
identifying active promoters in a specific environment, such as an animal host.
Active promoters are identified through the construction of a genomic library in
which the bacteria’s genomic DNA is randomly cut and cloned upstream of a
reporter gene. This gene will endow the cells with a specific phenotype (eg.
antibiotic resistance), allowing only those with active promoters to survive in a
particular environment. These transcriptional fusions can be placed on a plasmid
(82) or integrated into the bacterial chromosome (66). One of the most
significant advantages of IVET is its versatility. To date, four different variations
of IVET have been established, based on antibiotic resistance, auxotrophy,
system specificity, and recombination events involving a group of enzymes
known as recombinases, capable of excising a specific genetic marker (95).
These modified IVETs have been adapted and applied to a variety of Gram
positive (51, 52, 59, 116), Gram-negative (20, 38, 50, 114,117), Mycobacteria
(34) and eukaryotic microorganisms (96,110).
1.6.1.1 Antibiotic resistance selection
For antibiotic resistance based IVET, the reporter gene used is an
antibiotic resistance cassette. The most significant aspect of this IVET variant is
that it allows for the application of the IVET system in a wide variety of
microorganisms, both in vitro and in vivo, as all that is needed to detect active
promoters is to grow the cells in the appropriate antibiotic (82). One significant
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downfall of this particular selection method is that the antibiotic itself may impair
or modify the microorganism-host interaction when administered to the host
organism. For example, the host of X. campestris, the turnip, was shown to have
inhibited growth and chlorosis after extensive exposure to the antibiotic
chloramphenicol (82). This issue can be somewhat alleviated through the
administration of differing concentrations of antibiotic, as well as changing the
time at which the antibiotic is given (82, 95). This allows for the identification of
genes which are expressed at different antibiotic concentrations, as well as at
different time points.
1.6.1.2 Auxotrophic selection
The auxotrophy-based IVET strategy employs the use of a mutant strain
of the microorganism of study that is incapable of growth in the wild through the
mutation of a gene essential to normal growth, typically a biosynthetic gene (95).
This mutation can be complemented using the promoter trap; any DNA fragment
fused to the essential gene that becomes active will result in the expression of
the essential gene, allowing the microorganism to grow normally. The benefit of
this strategy is that virtually any biosynthetic gene required for wild-type growth
can be mutated so long as there are no metabolites in the environment that the
microorganism can use to complement the mutation (95). For example,
auxotrophic IVET studies have successfully mutated genes required for purine
biosynthesis (ApurA) in S. enterica serovar Typhimurium (66), methionine
biosynthesis (AmetXW) in Pseudomonas syringae (68) and pantothenate
biosynthesis (ApanB) in Pseudomonas fluorescens (93). Although versatile, one
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significant drawback to the auxotrophy-based IVET variant is that, for some
microorganisms, the necessary tools have yet to be developed to allow for the
construction of an auxotrophic mutant (95). For such microorganisms, another
form of IVET could be used to obtain the same results, such as the previously
described antibiotic resistance-based IVET.
1.6.1.3 System-specific selection
System-specific selection IVET is used to identify promoters which are
differentially expressed during a select stage of an interaction between a
microorganism and its eukaryotic host (95). It is similar to the auxotrophic IVET
system described previously, as it requires the construction of a mutant strain,
which can only be complemented with an active promoter region fused to a
reporter gene. However, instead of using a reporter gene that is essential for
wild-type growth, the reporter gene is one that is required for a specific stage
during a microorganism-host interaction. Thus, the microorganism is screened for
its ability to establish an interaction with its host (95). In addition to the
prototypical promoter trap element, the system-specific IVET variant also
measures the effect of the microorganism-host interaction on the host itself in
vitro, using a scorable host phenotype, such as cell lysis or symbiosis (95). This
system was used in symbiosis studies on the plant pathogen Sinorhizobium
meliloti where bacA, required for differentiation of the pathogen into bacteroids
(47), was used as a reporter gene for identifying host-induced promoter activity,
while gusA was used as a reporter gene for in vitro promoter activity (81). This
allowed the IVET system to screen for and identify genes that were only
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expressed before bacteroid differentiation, which only occurs during the
beginning stages of symbiosis (81).
1.6.1.4 Recombination in vivo expression technology
While the auxotrophic- and antibiotic resistance-based IVET variants have
distinct advantages, one of their largest disadvantages is that they are unable to
isolate transiently or weakly expressed genes over the course of an infection.
This issue is rectified by the recombination in vivo expression technology
(RIVET) variant (Figure 6). RIVET was designed by Camilli et al. in order to
identify Vibrio cholerae ivi genes in mice during the course of infection (15). With
RIVET, a reporter construct is integrated into a non-critical region of the bacterial
genome. The construct consists of a positive selection marker, such as an
antibiotic resistance cassette, which is flanked by specific recombinase
recognition DNA sequences. More recently, counter selective markers, such as
sacB, have been used in addition to the positive selection marker to create a
more robust reporter construct (71, 83). These sequences are specifically bound
to by a recombinase, such as Cre (3) or TnpR (59). The recombinase then
mediates a recombination event between the two recombinase recognition sites,
resulting in the excision of the reporter gene. Thus, RIVET works by constructing
a strain of the bacteria containing the reporter construct, and fusions of the
promoterless recombinase gene with random genomic DNA as described
previously. Fusions with active promoter regions result in expression of the
recombinase, leading to an excision event. Thus, cells with active promoters will
be deficient of the phenotype that the reporter gene provided. RIVET generally
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Figure 6: A general representation of the RIVET system, i) A reporter cassette
consisting of one or more reporter markers is flanked by two recombinase
recognition regions (blue), ii). A random fragment of genomic DNA (red) is cloned
upstream of a recombinase gene on a plasmid. If an active promoter is present in
the random DNA, it will drive expression of the recombinase gene (A plasmid
carrying a promoterless recombinase gene is used as a negative control). The
subsequent recombinase protein product will then bind to the recombinase
recognition regions, resulting in iii) excision of the reporter cassette. SM =
Selectable marker.

ûûû
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consists of two stages. The first involves the construction of the genomic DNA
library. Once completed, the library is screened to remove promoter regions
activated in vitro. For example, if the reporter gene is an antibiotic resistance
cassette, then the bacteria will be cultured in media containing the antibiotic to
which the cassette endows resistance to. Those harbouring constitutive
promoters will be killed, as the cassette has been excised by the recombinase,
resulting in antibiotic sensitivity. The second stage involves infecting the animal
host to identify active promoter regions. These can be identified using replica
plating, once the cells have been recovered from the host looking for colonies
which lack the reporter gene phenotype.
While RIVET is a powerful tool, other non-IVET based techniques can be
used to identify bacterial in vivo expressed genes. One of the most common of
these techniques is the microarray. Microarrays are capable of examining the
entire genome of a bacterium within a matter of hours, and output a huge
quantity of data which can be analyzed by a variety of computer software
programs. The benefit of using RIVET over microarray is that a RIVET system
can be established in virtually any molecular genetics laboratory using basic
molecular biology techniques, whereas microarrays are generally constructed in
special laboratories with the established equipment necessary for building and
analyzing microarrays, as these components can be quite expensive. Problems
can also arise due to the large quantities of RNA that are needed for a
microarray; this is particularly a problem with tissue samples, as they tend to
have low quantities of RNA that are insufficient for microarray analysis (100).
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Additionally, while microarrays do in fact identify when genes are expressed in
vivo, they can only do so at a specific time frame, specifically, that at which the
samples were extracted. RIVET, on the other hand, is capable of identifying
temporal gene expression throughout a time course, such as that of an infection.
1.7 Cre/loxP
A variety of recombinase systems exist that can be used to design a
RIVET system. One such system is the CrelloxP recombination system. Cre/loxP
was discovered in the P1 bacteriophage, as part of its site-specific recombination
system (111). The system is composed of Cre, a type I topoisomerase tyrosine
recombinase (80), and two loxP (locus of crossing over) sites. A loxP site is a 34bp DNA sequence consisting of two 13-bp inverted repeats that flank an 8-bp
asymmetric spacer region (43). A reporter construct, generally consisting of at
least one positive selection marker (eg. antibiotic resistance cassette) is cloned
in-between the two loxP sites.
cre encodes a 343-residue protein that has high binding specificity to loxP
sites. Each loxP site has two cre binding domains, each consisting of one of the
13-bp inverted repeats plus the first 4-bps of the spacer region adjacent to the
inverted repeat (44). Once the Cre has bound to these domains on two different
loxP sites (only two molecules of Cre are required per loxP site (63)), a
recombination event occurs in which one of three outcomes can be observed for
the DNA flanked by the loxP sites: excision, inversion or translocation (Figure 7).
Translocation occurs when recombination is between two loxP sites located on
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Translocation occurs when recombination is between two loxP sites located on
separate DNA strands. Excision and inversion occur when the loxP sites are on
the same strand of DNA; the event that occurs is dictated by the directionality of
the loxP spacer region (45). If the spacer region of the loxP sites are direct
repeats in relation to each other, then an excision event will occur. However, if
the spacer regions of the loxP sites are inverted in relation to each other, then an
inversion event will occur.
1.8 The use of an IVET system in S. aureus
In 1998, Lowe etal. successfully implemented an antibiotic resistancebased RIVET system in S. aureus (59). The system successfully identified 65 ivi
staphylococcal genes in a murine renal abscess model, 45 of which were
strongly induced. Only six of these genes were known staphylococcal virulence
determinants, including agrA, a part of the global regulatory system (79), and geh,
which encodes the glycerol ester hydrolase gene (49). The remaining 39 genes
were either previously unknown ivi genes, or had homology to known non
staphylococcal genes. This subsequently led to the identification and sequencing
of murC, which encodes a UDP-N-acetylmuramoyl-L-alanine synthetase, an
essential component for cell wall biosynthesis (60).
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Figure 7: The three possible outcomes of CrelloxP recombination. If the
orientation of two loxP spacer regions (blue arrows) are in the same direction,
then all DNA enclosed by the loxP sites is excised (Top). If the orientation of two
loxP spacer regions are inverted in respect to each other, then all DNA enclosed
by the loxP sites is inverted (Centre). If two loxP sites are on separate strands of
DNA, then a translocation will occur (Bottom).
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1.9 Thesis and Research Objectives
Although the S. aureus based RIVET system designed by Lowe et al.
proved to be successful in identifying ivi genes during a S. aureus infection,
several modifications can be made in order to improve the system. One such
modification would be the addition of a counter selection marker. This, combined
with an antibiotic reporter gene could result in a reduction in the number of false
positive colonies obtained using the RIVET system. Therefore, an improved S.
aureus IVET system utilizing the RIVET strategy would be considerably
beneficial in the identification of ivi genes, as well as determining the temporal
expression of these genes. Such data could provide considerable insight into
how S. aureus functions in vivo during an infection.
The goal of this project was to design and construct a RIVET-based
system in S. aureus, and use it to determine the temporal expression of ironregulated promoters during growth in an iron-starved environment, both in vitro
and in vivo. To that end, my research objectives consisted of developing a RIVET
based system containing a loxP reporter cassette with both a positive selection
marker and a counter selection marker. This loxP cassette would then be
integrated into the chromosome of several S. aureus strains through the use of a
single homologous recombination event. Single- and multi-copy ere constructs
driven by different promoter constructs were to be built and transformed or
integrated into strains of S. aureus containing the loxP cassette. Expression from
promoters would be monitored through ere expression resulting in the loss of the
loxP reporter cassette. My hypothesis states that excision of the loxP reporter
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cassette would only occur in those cells cultured in conditions where promoter(s)
were active. This would represent a valuable laboratory tool for use in gene
expression studies, especially in vivo during S. aureus infection.
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Chapter 2: Methods and Materials
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2.1 Bacterial strains, plasmids, and growth media
2.1.1 Bacterial cell cultures
All bacterial strains and plasmids used in this study are outlined in Tables
3 and 4. All bacteria were cultured at 37°C. If required, antibiotics were used at
the following concentrations: ampicillin (100 pg/mL), chloramphenicol (30 pg/mL)
erythromycin (300 pg/mL), kanamycin (50 pg/mL), spectinomycin (50 pg/mL) and
tetracycline (10 pg/mL) for E. coli cultures; chloramphenicol (5 pg/mL)
erythromycin (3 pg/mL), kanamycin (50 pg/mL), lincomycin (50 pg/mL), neomycin
(50 pg/mL) and tetracycline (4 pg/mL) for S. aureus cultures. All E. coli cultures
were grown in Luria-Bertani (LB) broth (Difco), while tryptic soy broth (TSB)
(EMD Biosciences) was used to culture S. aureus. Solid media was obtained by
the addition of agar (EMD Biosciences) to 1.5% w/v In select experiments,
E. coli was grown on LB agar with 40pg/mL 5-bromo-4-chloro-3-indoyl-(3-Dgalactopyranoside (X-Gal) and 0.1 mM isopropyl beta-D-thiogalactopyranoside
(IPTG).
Iron-restricted media used to culture S. aureus was made by adding the
divalent cation chelator 2,2'-dipyridyl (Sigma-Aldrich) to a concentration of 1mM.
All media and solutions were made with double distilled water.
2.2 DNA preparation
2.2.1 Isolation of plasmid DNA
Plasmid DNA was isolated from E. coli using e.Z.N.A™ plasmid mini prep
kits (Omega Bio-Tek), as directed. S. aureus plasmid DNA was isolated using
Qiaprep mini-prep spin kits (Qiagen). In addition to the standard Qiaprep protocol,
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Table 3: Bacterial strains used in this study

Bacterial strains_________Description_______________________ Reference
Bacteria
E. coli
DH5a

XL1-Blue

aureus
RN4220
RN6390
Newman
SH1000
H2067
H2073
H2116
H2187
H2188
H2219
H2218

Promega
F- 4>80 dLacZAM15 recA1 endA1 gyrA96 Í/7/-1
hsdR17(rk' mk+) supE44 relA1 deoR
A{lacZYA-argF)\J169
endA1 gyrA96(nal ) thi-1 recA1 relA1 lac glnV44 Stratagene
F'[ ::Tn10 proAB+ laclq A(lacZ)M15]
hsdR17(r«' mK+)
rk" mk+; accepts foreign DNA
Prophage cured wild type strain
Wild-type clinical isolate
r s b lf derivative of S. aureus strain 8325-4
RN4220: :loxR, TetR
RN6390: :loxR, TetR
Newman: :/oxP, TetR
RN4220::/oxP with integrated
promoterless ere vector; EryR
RN4220::/oxP with integrated PFhuCBc::cre
transcriptional fusion; EryR
RN6390: :/oxP with integrated promoterless
ere construct; EryR
RN6390::/oxP with integrated P F hu C B G ''ere
construct; EryR
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54
86
35
46
This
This
This
This

Study
Study
Study
Study

This Study
This Study
This Study

Table 4: Plasmids used in this study

Plasmids______________ Description_______________________ Reference
pSHE11
pDG1513
pDG646
pLI50
pAW11
pTL.2787
pLL29
pLL29-Ery
pSAKO
pBC SK (+)
pCM6
pCM13
pCM14
pCM15
pCM17

pCM19
pCM21

104
E. coli Cre expression vector; AmpR
41
pMTL22 derivative carrying a tetracycline
resistance cassette; AmpR
41
pSB119 derivative carrying an erythromycin
resistance cassette; AmpR
56
E. colilS. aureus shuttle vector; ApR CmR
115
E. colilS. aureus shuttle vector; EryR
65
Carries <J>11 int
65
S. aureus single-copy integration vector; TetR
This Study
pLL29 with TetR cassette disrupted by an
erythromycin cassette
30
S. aureus gene deletion plasmid containing
sacß[Bsub]W29; KmR
Stratagene
E. coli cloning vector; CmR
P ig t: :sacB transcriptional fusion cloned into pLI50; This Study
AmpR CmR
This Study
Completed loxP construct in pBC SK(+); Cm
Promoterless cre construct cloned into pAW11; This Study
EryR
This Study
PF h u c B G - •cre transcriptional fusion
cloned into pAW11; EryR
This Study
P F h u C B G ::cre transcriptional fusion
cloned into pLL29-Ery; SpecR (E.coli)
EryR(S. aureus)
This Study
promoterless cre cloned into pLL29-Ery;
SpecR (E.coli) EryR(S. aureus)
This Study
P F h u C B G : :A1-27cre transcriptional fusion
cloned into pAW11; EryR
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S. aureus cells were incubated in P1 resuspension buffer containing 50 pg/mL
lysostaphin for 30-60min before the addition of lysis buffer P2.
2.2.2 Isolation of S. aureus chromosomal DNA
S. aureus chromosomal DNA was obtained using the protocol outlined in
(91). Briefly, 5 mL S. aureus cultures were grown overnight, with shaking. 500 pL
of culture was spun down for 2 minutes at 7000 rpm. The supernatant was
decanted, and 200 pL STE (75 mM NaCI, 25 mM EDTA, 20 mM Tris pH 7.5) was
used to wash the pellet. The cells were spun down again for 2 minutes at 7000
rpm, and the supernatant decanted. 50 pg lysostaphin was dissolved in 200 pL
STE to create a STE/lysostaphin buffer. 25 pL of the STE/lysostaphin buffer was
used to resuspend the cell pellet, and incubated for 1 hour at 37°C. 20 pL 10%
SDS and 20 pL proteinase K were then added and the entire mixture incubated
at 55°C overnight. 80 pL 5 M NaCI was then added; the resulting solution was
mixed by inversion. 320 pL 25:24:1 phenol/chloroform/isoamyl alcohol was
added and mixed by inversion and the resulting mixture was allowed to incubate
at room temperature for 30 min, then spun down at 12000 rpm for 10 min. The
aqueous layer of solution was removed using a wide bore tip and placed in a
separate eppendorf tube. 300 pL 25:1 chloroform/isoamyl alcohol was mixed with
the aqueous layer by inversion and spun down at 12000 rpm for 10 min. The
aqueous layer was removed, and 400 pL isopropanol was added and the mixture
was incubated at room temperature for 10 min, then spun down at 12000 rpm for
5 min. The supernatant was decanted, and the pellet was washed with 100 pL
95% ethanol. Pellets were dried and resuspended in 100 pL ddH20.
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2.2.3 DNA sequencing
DNA samples sent for sequencing had a minimum DNA concentration
of 150ng/pL. Primers used for sequencing had a concentration of 12 pmol. All
DNA sequencing was performed at the York University Core Molecular Biology
and DNA Sequencing Facility.
2.3 Recombinant DNA methodology
2.3.1 Manipulation of recombinant DNA
All restriction endonuclease digestions, PCR reactions and DNA ligations
were performed as outlined by Sambrook et at. (97). Restriction endonucleases,
rAPid alkaline phosphatase and Pwol polymerase were obtained through Roche
Diagnostics. T4 DNA ligase and additional restriction endonucleases were
obtained from New England Biolabs. T4 polynucleotide kinase was obtained from
Fermentas. All oligonucleotides detailed in Table 5 were purchased from
Integrated DNA technologies.
2.3.2 Preparation of competent E. coli and S. aureus cells
For E. coli DH5a CaCh competent cells, 400 mL LB broth was inoculated
to an ODeooof 0.01 with an overnight culture of E. coli DH5a, and incubated at
37°C with aeration until ODeoo reached 0.5. Cells were placed on ice for 20
minutes, then centrifugated for 10 minutes at 3000rpm, 4°C. The supernatant
was carefully decanted so as to not disturb the pellet. The pellet was
resuspended in 100 mL chilled E. coli competent cell buffer (0.1 M CaC^, 15%
v/v glycerol), placed on ice for 30 minutes, then spun down for 10 minutes at
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Table 5: Oligonucleotides used in this studya,b

Sequence (5‘ -> 3’)

Name
loxP For

loxP Rev

Ery For
Ery Rev
Promoterless ere For
ere For
ere Del For
ere Rev
fhuCBG For
fhuCBG Kpn\ Rev
fhuCBG Xba\ Rev
TetRFor
TetR Rev
tRNA-Lys For
tRNA-Leu Rev
Igt promoter For
Igt promoter Rev
sacB For
sacB Rev

TGAGCTÇATAACTTC GTATAG CATACATTATAC GA
AGTTAT GATATCATAACTTCGTATAG CATACATTAT
ACGAAGTTATAGGTACCA
TGGTACCTATAACTTCGTATAATGTATGCTATACG
AAGTTAT GATATÇATAACTT CGTATAAT GTATG CT
ATACGAAGTTATGAGCTCA
CGCGATATCTTACTTATTAAATAATTTATAGC
CCCGATATCTTTAACTCTGGCAACCC
TTGTCTAGAATGTCCAATTTACTGACCGTACACC
TT GGGIAÇÇAT GTCCAATTTACTGACCG
TTGTCTAGAATGGACATGTTCAGGGATCG
ATACTGCAGCTAATCGCCATCTTCCAGC
GGGGAATTÇGATTTAT CAAATTAAGTG C
GGGGGTACCAATTTCCCTACTTTCAATAAAATTC
GGGTCTAGAAATTTCCCTACTTTCAATAAAA
CCCTCTAGACTCGAGGCAGATAGTGTACGTAAA
AAG
GCGTCTAGATTAGAAATCCCTTTGAGAATG
TTGGAGCTCGCCATTAGCTCAGTTGG
TTCGAGCTCATTTTGAGTCCCGCG
GGCGATATCCCCGGGTTTCTTTTCGAAATTC
CATCTTCATATGGGGTTCACCTCAATT
CTCCATATGAACATCAAAAAGTTTGCAA
CCCGATATCTCTAGATTATTTGTTAACTGTTAA
TTGTCC

aRestriction sites used for cloning are underlined
bAbbreviations: tetR: tetracycline resistance
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3000rpm, 4°C. The supernatant was carefully decanted and the pellet
resuspended in 4mL E. coli competent cell buffer. 10OpL aliquots were placed in
sterile 1,5mL eppendorf tubes, flash frozen on dry ice, and stored at -80°C.
For all S. aureus competent cells, 200mL TSB was inoculated to an ODeooof
0.01 with an overnight culture of the desired S. aureus strain and incubated at
37°C with aeration until ODeoo reached 0.3. Cells were put on ice for 10 minutes,
then spun down for 10 minutes at 3000rpm, 4°C. The supernatant was carefully
decanted, and the pellet resuspended in 20ml_ chilled 0.5 M sucrose, then spun
down for 10 minutes at 3000rpm, 4°C. The supernatant was carefully decanted
and the pellet resuspended in 2.5 mL 0.5 M sucrose. The resuspended cells
were incubated on ice for 20 minutes then spun down for 10 minutes at 3000 rpm,
4°C and resuspended in 2 mL 0.5 M sucrose. 60 pL aliquots were placed in
sterile 1.5 mL microcentrifuge tubes, flash frozen on dry ice and stored at -80°C.
2.3.3Transformation of competent E. coli and S. aureus cells
Competent DH5a E. coli cells were thawed on ice. 5 pL of plasmid DNA or
10 pL ligation mixtures were added to the cells and incubated on ice for 40
minutes, heat shocked at 42°C for 2 minutes then cold shocked for 2 minutes.
700 pL LB broth was added to the cells which were then incubated at 37°C for
one hour. 100 pL of cells were then plated on selective agar and incubated at
37°C overnight. The remaining 600 pL of cells were spun down and the
supernatant decanted. The pellet was resuspended with 100 pL fresh LB and
subsequently plated as previously described.
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Competent S. aureus cells were thawed on ice. 3 pL of plasmid DNA was
added to the cells and incubated on ice for 20 minutes, then placed in a 0.2 cm
electroporation cuvette and electroporated using a BioRad Gene Pulser (one
pulse at 2.5 kV, capacitor at 25 pF, parallel resistor at 100 Q, time constant of 2.5
ms). 700 pL TSB was immediately added to the cells which were subsequently
incubated at 37°C for one hour. The cells were then spun down and the pellet
resuspended with 100 pL fresh TSB. The cells were then plated on selective agar
and incubated at 37°C overnight.
2.3.4 Construction of Pigt::sacB fusion
The Igt promoter region was PCR amplified from S. aureus Newman
chromosomal DNA using primers Igt promoter For and Igt promoter Rev. sacB
was PCR amplified from the suicide vector pSAKO using the primers sacB For
and sacB Rev. The Igt promoter region and sacB were digested with Nde\,
ligated and PCR amplified resulting in a Pigt: sacB fusion. Pigt::sacB was
phosphorylated, and blunt cloned into a dephosphorylated Smal site in the E. coli
- S. aureus shuttle vector, pLI50.
2.3.5 Construction of pLL29-Ery
pLL29 is a S. aureus single-copy integration vector based on the
lysogenic bacteriophage L54a and <p11 site-specific recombination systems (62).
The plasmid harbours a tetR cassette, which, for the purposes of this study,
needed to be inactivated. To do this, an erythromycin resistance cassette was
_

D

cloned into pLL29 using a unique EcoRV site located within the Tet cassette.
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The erythromycin cassette was PCR amplified from pDG646 using the Ery For
and Ery Rev primers. The PCR product was then cut with EcoRV and blunt
cloned into the dephosphorylated pLL29 backbone using the aforementioned
EcoRV site, disrupting the tetRcassette and resulting in pLL29-Ery.
2.3.6 Construction of PFhuCBo'-'cre fusion
The fhuCBG promoter region (Figure 8) was PCR amplified from the S.
aureus Newman chromosome using the fhuCBG For and fhuCBG Kpn\ Rev
primers, ere was PCR amplified from pSHE11 using the ere For and ere Rev
primers. The promoter region and ere were then digested with Kpn\, ligated and
PCR amplified resulting in PFhuCBG::cre. The resulting fusion was then cloned into
either the E. coli-S. aureus shuttle vector pAW11, or the single copy S. aureus
integration vector pLL29-Ery using the unique EcoRI and Psti sites. As a control,
a promoterless ere construct was PCR amplified using the Promoterless ere For
and ere Rev primers, then cloned into pAW11 or pLL29-Ery using unique X£>al
and EcoRI sites.
2.3.7 Construction of PFhuCBc::A1-27cre fusion
The fhuCBG promoter region was PCR amplified as described in 2.3.6
with a single modification: The fhuCBG Xba\ Rev primer was used to PCR
amplify the promoter region instead of the fhuCBG Kpn\ Rev primer. A truncated
ere with the first 27 amino acids deleted from the N-terminus was PCR amplified
using ere Del For and ere Rev primers. The fhuCBG promoter and truncated ere
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Figure 8: The fhuCBG promoter region of S. aureus strain Newman. The ShineDalgarno (SD) site, -35 and -10 regions of the promoter region are underlined
and the boxed sequence represents the iron-regulated Fur box. The translation
start methionine is depicted in red. Sequence downstream, and including the
ATG start-codon is the beginning of fhuC.

NWMN_698191 ATAAAT GGTAT GAGCACACATACTTAAATAGAAGTCC ACGG
NWMN_698232 ACAAGTTTTTGAACTATGAAGACTTATCTGTGGGCGTTTTTT
NWMN_698274 ATTTTATAAAAGTAATATACAAGACATGACAAATCGACAATT
NWMN 698316 TAAAAAGTAATGTTAGTÇAATAAGATTGAAAAATGTTATAAT
^____________________ -35
-10
NWMN_698358|GAT GTTCAT GATAATCÂ^TAT CAATTGGGATGTCTTTGAAAA
NWMN_698400 TTGATAATTTAAAAATAGAAATTATTTTTTATAAACAGAAAGA
NWMN 698443 AATTTTATTGAAAGTAGGGAAATTATGAATCGTTTGCATTGG
SD

NWMN_698485 ACAACAAGTTAAAATT GGTTAC GGGGATAACAC GATTATAA
NWMN 698526 ATAAATTAGATGTTGAAATAC
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were digested with Xba\, ligated and PCR amplified, resulting in the

P

f iu ic b g ^ a

I-

27ere fusion, which was then cloned into the pAW11 backbone using unique
EcoRI and Pst\ sites, creating pCM21.
2.3.8 Construction of the loxP cassette
25 pL of primers loxP For and loxP Rev, consisting of two loxP sites
separated by an EcoRV site, were mixed in a PCR tube and annealed together in
a thermocycler by gradually increasing the temperature up to 95°C, at a rate of
0.1°C/sec. The resulting 87 bp PCR product was cloned as a Sac\IKpn\ fragment
into pBC SK+, creating pCM5. The Pigt:.sacB transcriptional fusion was cut with
EcoRV and cloned into the aforementioned EcoRV site into the
dephosphorylated pCM5 backbone, resulting in pCM11. A 2.1 kb fragment
containing a tetracycline resistance cassette and its native promoter was PCR
amplified from pDG1513 and amplified using the TetRFor and TetRRev primers,
cut with Xba\ and cloned into a unique Xba\ site of pCM11, which had been
dephosphorylated beforehand, resulting in pCM12. To complete the loxP
construct, a 2.2 kb fragment flanked by a truncated tRNA-Leu and a tRNA-Lys
was PCR amplified from the Newman chromosome (NWMN_tRNA24 to
NWMN_tRNA44) using the tRNA-Lys For and tRNA-Leu Rev primers. The PCR
product was then digested with Sacl and cloned into the unique Sacl
(dephosphorylated) site outside of the loxP cassette in pCM12, resulting in
pCM13.
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2.4 Integration of the loxP cassette into the S. aureus chromosome
E. coli harbouring the pCM13 plasmid was cultured overnight. Plasmid
preparations of pCM13 were performed until a plasmid concentration of
approximately 1 mg/pL was attained. pCM13 was then electroporated into
competent S. aureus strain RN4220 cells and plated on TSB agar containing
tetracycline and incubated overnight at 37°C. Three transformants were obtained.
Each was tested to verify loxP construct integration by PCR amplification of the
tetracycline resistance cassette, as well as sacB, using the chromosomal DNA of
the transductants as a template (data not shown). Once verified, the loxP
cassette was transferred from the RN4220 background to other S. aureus strains
using phage transduction. Transductions, using phage 80a, were carried out as
described previously (78).
2.5 Integration of ere constructs into the S. aureus chromosome
ere constructs were integrated as described (62). Briefly, E. coli
harbouring a ere construct plasmid were grown overnight. The ere plasmids
were then transformed into competent S. aureus strain RN4220 cells and plated
on TSB agar containing erythromycin and lincomycin. ere construct integration
was then verified by PCR amplification of the ere gene using the chromosomal
DNA of each integration strain as the template. Colonies with verified ere
constructs were then transduced, using phage 80a, to other S. aureus strains as
described in 2.4.
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2.6 Determining frequency of loxP cassette resolution before inoculation of liquid
media
Colonies harbouring one of the three ere constructs were patched onto
two different plates: TSB agar containing erythromycin and lincomycin and TSB
agar containing erythromycin, lincomycin and tetracycline. Patched colonies were
grown overnight at 37°C, then observed for tetracycline sensitivity.
2.7 Cassette resolution in S. aureus strains carrying the loxP cassette
To verify the functionality of the CreiloxP system, each multi-copy ere
construct was electroporated into RN4220. Plasmids were prepared from
RN4220 as described above and electroporated into RN6390: :/oxP, plated and
grown overnight at 37°C for no more than 18 hours. Three colonies were
randomly selected and separately resuspended in 300 pL TSB. 200 mL fresh
TSB containing erythromycin and lincomycin were inoculated with the
resuspended cultures to an OD6oo= 0.01. The inoculated 200 mL of TSB was
then split in half, with sterilized 2,2’-dipyridyl added to one of these flasks to a
concentration of 1mM. Aliquots of each culture were taken every 2 hours and
plated on both TSB agar containing erythromycin and lincomycin and TSB agar
containing erythromycin, lincomycin and tetracycline, using serial dilutions. Cells
were grown for a minimum 18 hours at 37°C, and CFUs were counted. This was
repeated using the single-copy promoterless ere and Pfciiucbg: ere constructs.
2.8 Bacterial growth curves
S.

aureus cultures were grown for 20 hours in TSB with the appropriate

antibiotics. Cultures were diluted to an ODeoo of 0.01 in TSB or TSB + 10%
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sucrose and grown at 37°C under constant shaking in a bioscreen C machine
(Growth Curves, USA). Optical density was measured at 600nm once every half
hour for 48 hours.
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Chapter 3: Results
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3.1 A Tetracycline-resistance cassette as a suitable positive selection marker
In order to construct a loxP reporter cassette (Figure 9), a positive
selective marker needed to be chosen. An antibiotic resistance cassette was
used, as several of these cassettes encoding for Kan , Ery /Line and Tet have
all been used effectively by our laboratory in a variety of S. aureus genetic
backgrounds (5, 101). Thus, a TetR cassette was chosen as the selective marker
for use in this loxP reporter cassette; both single- and multi-copy vectors carrying
a TetRcassette (See methods and materials) were tested in several S. aureus
strains, all of which endowed a TetR phenotype to previously Tets strains (data
not shown).
3.2 sacB as a suitable counter selection marker
A counter selective marker was chosen to allow S. aureus cells lacking the
loxP reporter cassette to grow in selective media in order to easily differentiate
those in which the reporter cassette had not been excised. Previous studies have
used sacB from Bacillus subtilis as a counter selective marker in a RIVET system
(83). sacB imparts a sucrose-sensitive phenotype; cells carrying sacB grown in
the presence of sucrose are killed due to a continued buildup of levan, the end
product of levansucrase fructosyl group polymerization and sucrose hydrolysis
(10). In addition, the sucrose-sensitive phenotype of sacB has been shown to
work in S. aureus (30); however, it was only tested in the RN4220 genetic
background. Thus, it needed to be determined if other S. aureus genetic
backgrounds could become sucrose-sensitive using sacB. sacB was fused to the
constitutive promoter of the lipoprotein diacylglycerol transferase encoding Igt, a
55
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Figure 9: Schematic of a loxP reporter cassette integrated into the S. aureus
chromosome. The cassette consists of a positive selection marker (PSM) and a
counter selection marker (CSM) flanked by two loxP sites, and is integrated using
genomic DNA from S. aureus in order to perform a single homologous
recombination event (SHR DNA).

ATAACTTCGTATAGCATACAITATACGAAGTTAT

ATAACTTCGTATAGCATACATTATACGAAGTTAT

T A T T G A A G C A T A T _________

TATTG AAG CATAI___ ______ATATGCTTCAATA

A T A T G fT IT A ATA
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known S. aureus virulence determinant (12), creating the Pigt: sacB
transcriptional fusion. This fusion was then cloned into pLI50 (See methods and
materials), creating pCM6. pCM6 was electroporated into four different S. aureus
strains: RN4220, RN6390, Newman and SH1000. 10pL aliquots of each strain
were then grown overnight on TSB agar containing no sucrose, 5%, 10% or 15%
sucrose (Figure 10). Sucrose sensitivity was readily apparent in all strains
containing pCM6 with the exception of the Newman strain at 5% sucrose (Figure
10A). However, at 10% and 15% sucrose all strains containing pCM6, but not
those containing the vehicle control showed sucrose sensitivity. The RN4220,
RN6390 and SH1000 strains all maintained a similar level of sucrose sensitivity
at both the 10% and 15% sucrose concentrations, with only the Newman strain
showing a significant increase in sucrose sensitivity at 15%. In contrast, the
same strains containing the pLI50 empty vector displayed no sensitivity to
sucrose, regardless of sucrose concentration (Figure 10B), showing that the
sucrose sensitivity is due to the P^. sacB fusion.
Next, three S. aureus strains containing a genome-integrated P\$::sacB
fusion were tested for a sensitivity to sucrose at the same sucrose concentrations
as those used to test the plasmid-based P^/sacB construct described above
(Figure 11). Interestingly, of the three strains tested, only RN6390 appeared to
show a slight sensitivity to sucrose against its wild-type counterpart in any of the
sucrose concentrations tested. Unlike the plasmid-based P^/.sacB harbouring
strains, where sensitivity to sucrose was readily apparent (significantly less cell

58

59

Figure 10: Verification of the sacB phenotype in S. aureus using a plasmid
carrying sacB expressed from the constitutive Igt promoter. The plasmid was
electroporated into four different S. aureus strains: RN4220, RN6390, Newman
and SH1000. The strains were serially diluted, then plated onto varying
concentrations of sucrose. All four strains containing pCM6 showed signs of
sucrose sensitivity at a sucrose concentration of 10%. A) S. aureus strains with
the empty vector control. B) S. aureus strains with the Pigt::sacB carrying plasmid.

No sucrose

5% sucrose

10% sucrose
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15% sucrose
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Figure 11: Verification of the sacB phenotype in S. aureus strains with the
genome-integrated P^y.sacB fusion. This fusion was tested to evaluate a
sucrose sensitive phenotype in RN4220, RN6390 and Newman at varying
sucrose concentrations. Of these strains, only the RN6390 carrying the
integrated Pigt::sacB fusion presented with a minor sucrose sensitive phenotype.
The phenotype could be seen on all plates containing sucrose. Wild-type strains
without the integrated P^ .sacB fusion were used as controls.

10%

sucrose

15% sucrose
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growth in comparison to strains with the empty vector), sucrose sensitivity in the
RN6390 strain with the genome-integrated P^::sacB strain was poor,
represented by limited growth and smaller CFUs versus the wild-type in the final
dilution only at all three sucrose concentrations. Due to the limited sucrose
sensitivity shown in the three S. aureus strains with the genome-integrated
Pigt:.sacB fusion, a different approach was taken to verify the sacB phenotype in
these strains. Instead of observing sucrose sensitivity on agar plates, I grew each
strain for 48 hours in liquid TSB with or without sucrose (Figure 12). Both the
RN4220 and Newman strains with the genome-integrated Pigt..sacB fusion did
not show any sucrose sensitivity (Figure 12A, B). The RN6390 strain harbouring
the integrated single-copy P^ sacB fusion, however, showed significant cell
growth impairment in the presence of sucrose, as the OD600 was far lower in the
presence of sucrose than that seen without sucrose (Figure 12C). Curiously, in
the presence of sucrose cell growth of the same strain gradually increased until
hour 30, at which point growth began to decrease once again. It is important to
note that growth levels of the RN6390 with the genome-integrated Pigt::sacB
fusion in the presence of sucrose never attained those of the same strain in the
absence of sucrose. This indicates that the RN6390: loxP strain is sensitive to
sucrose. In addition, because the RN6390 wild-type strain showed similar growth
curves regardless of the sucrose concentration, the sucrose sensitivity seen in
the RN6390 strain is due to the genome-integrated Pigt: sacB fusion. Based on
these results, only the RN6490: :/oxP strain was used to test for loxP cassette
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Figure 12: Verification of the sacB phenotype in S. aureus strains with the
genome-integrated Pigt::sacS in liquid cultures over 48 hours. Strains were grown
in a bioscreen in TSB with or without sucrose. Only the RN6390 strain carrying
the Pigt::sacB fusion showed a sucrose sensitive phenotype in the presence of
sucrose (C). This phenotype was readily apparent until hour 16. Growth then
steadily increased until hour 32, at which point cell growth began to deteriorate.
Both the RN4220 (A) and Newman (B) strains with the integrated P^ sacB did
not show sucrose induced cell death in the presence of sucrose. Wild-type
strains without the genome-integrated Pigt::sacB were used as controls for each
strain.

c
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resolution with the ere expression constructs.
3.3 Construction of the S. aureus loxP reporter strain
In order to determine temporal expression of iron-regulated S. aureus
promoters, a S. aureus strain harbouring a loxP reporter cassette needed to be
constructed (Figure 13). Two loxP sites flanking an EcoRV site were cloned into
pBC SK+, a plasmid containing no Gram-positive origin of replication (ori),
resulting in pCM5. The P)gt sacB fusion was then cloned in-between the loxP
sites of pCM5, creating pCM11. A tetracycline resistance cassette from pDG1513
was then cloned downstream of the P^ .sacB fusion resulting in pCM12. Finally,
a tRNA fragment flanked by a truncated tRNA-Leu and a tRNA-Lys from the S.
aureus Newman chromosome was cloned outside of the loxP cassette, resulting
in the completed loxP reporter cassette, pCM13. This tRNA fragment would allow
for a single homologous recombination event to occur, resulting in the integration
of pCM13 into the S. aureus chromosome. pCM13 was electroporated into S.
aureus strain RN4220 and grown on TSB agar with tetracycline overnight. Due to
pCM13 lacking a Gram-positive ori, only cells that had pCM13 integrated into the
chromosome could grow on the tetracycline plates. Three TetRcolonies were
obtained. Verification of a successful integration event was done by PCR
amplifying the TetRcassette as well as sacB using chromosomal DNA as the
template; all three colonies contained the integrated loxP cassette (Data not
shown). The loxP cassette was then transduced into the RN6390 and Newman
genetic backgrounds, creating RN6390: loxP and Newman::/oxP.
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Figure 13: Construction of the loxP reporter cassette. A. The loxP sites were
cloned into pBC SK+ using the Sacl and Kpn\ sites, effectively removing the
MCS of pBC SK(+) and creating pCM5. The Pigt.:sacB transcriptional fusion was
then cloned between the loxP sites, resulting in pCM11. A TetRcassette from the
pDG1513 vector was then cloned into pCM11, resulting in pCM12. Finally, a
tRNA fragment from S. aureus Newman was cloned into pCM12 outside the loxP
cassette, resulting in pCM13. B. Linear map of pCM13 showing relevant genetic
loci; not drawn to scale.
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Successful transductants were verified by PCR as previously described (Data not
shown).
3.4 Construction of the S. aureus multi-copy ere expression vectors
In addition to the S. aureus loxP reporter strains, ere expression systems
needed to be constructed in order to test for resolution of the loxP cassette. To
do this, a S. aureus iron-regulated promoter needed to be chosen in order to test
for successful ere expression. The fhuCBG promoter was selected, as its
ATPase, FhuC, is used in conjunction with several of the S. aureus iron
acquisition systems (See Figure 5). Thus, ere was fused to the fhuCBG promoter
region, resulting in a

PFhuC B G

-ere fusion. The fusion was then cloned into the E.

c o li- S. aureus shuttle vector pAW11, resulting in pCM15. A promoterless ere
was also cloned into pAW11 as a negative control, creating pCM14. An
additional control using a ere in which the first 27 amino acids were deleted was
fused to the fhuCBG promoter (PFhuCBG::A1-27cre) and subsequently cloned into
the pAW11 backbone, resulting in pCM21.
3.5 Resolution of the loxP cassette using multi-copy iron-regulated Cre
expression in S. aureus strain RN6390: loxP
In order to confirm that the PFhuCBG::cre construct was expressing Cre,
three differen multi-copy cre constructs were built: PFhuCBG--cre, a promoterless
cre construct, and PFhuCBG::A1-27cre, containing an inactive cre gene. Each
construct was transformed into RN6390: loxP then grown n in either iron rich or
iron starved conditions over 12 hours (Figure 14). Aliquots from each condition
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Figure 14: Sequential diagram of the RIVET system designed to elucidate the
temporal expression of S. aureus iron-regulated promoters. Plasmids containing
ere expressed by iron-regulated promoters, are introduced into S. aureus strains
harbouring the integrated loxP cassette. Cells are simultaneously cultured in iron
rich (A) and iron starved media (B). Aliquots are serially diluted onto TSB agar
with or without tetracycline and grown overnight. In the iron rich conditions, no
ere expression should be observed, and abundant cell growth should be seen on
the tetracycline plates. In the iron starved environment however, the ironregulated ere should express ere resulting in excision of the loxP cassette,
making those cells sensitive to tetracycline, resulting in reduced CFU counts on
the tetracycline plates in comparison to the plates containing no tetracycline.

A

T e tra c y c lin e
P la te s

Abundant
colonies

T e tra c y c lin e
P la te s
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were serially diluted on plates with or without tetracycline in order to verify loxP
cassette resolution. As expected, both the promoterless ere and PFhuCBG” A121 ere multi-copy constructs did not show any resolution of the loxP cassette in
either iron environment, as there was no significant difference between cells
grown on the plates with tetracycline in comparison to those grown on plates
without tetracycline (Figures 15A, B). The PFhuCBG::cre multi-copy construct,
however, shows cassette resolution in both the iron rich and iron starved growth
environments (Figure 15C). While resolution is observed regardless of the
environmental iron available, it is apparent that resolution was higher in the iron
starved media due to iron-regulated ere expression via the fhuCBG promoter. It
is important to note that unlike the promoterless ere and PFhuCBG::A1-27cre
constructs, data from only one colony is shown for the PFhucBG- 'cre construct.
This is due to the remaining two replicates having no growth on the tetracycline
plates at all time points (data not shown), indicating that resolution of the
cassette occurred before the colonies were used to inoculate the TSB media.
Patching additional colonies onto agar plates with or without tetracycline showed
that two out of five colonies (40%) had their cassette resolved during cell growth
after electroporation of the PFhuCBG^cre plasmid construct into RN6390: loxP.
Taken together, these results indicate that, while ere is being expressed by the
PFhuCBG::cre construct, its multi-copy nature may be causing artificially high levels
of ere expression, causing early loxP cassette resolution. Therefore, single-copy
ere constructs needed to be tested to verify this.
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Figure 15: Resolution of the loxP cassette using multi-copy iron-regulated Cre
expression in S. aureus strain RN6390 ..loxP. CFUs were counted over a 12 hour
time period in either an iron rich environment (TSB media or iron starved media
(TSB media + 1mM 2, 2’-dipyridyl) and plated on agar with (+Tet) or without
tetracycline (-Tet). Cassette resolution would be observed if a reduced number of
colonies were observed on the + tet plates in comparison to the -te t plates.
RN6390::loxP cells harbouring the promoterless cre (A) or P r ,ucbg::A1-2 7cre (B)
constructs did not show any evidence of cassette resolution, regardless of what
iron environment the cells were cultured in. However, RN6390: loxP cells
harbouring the PFhuCBG--cre plasmid showed definitive cassette resolution in both
the iron rich and iron starved environments, indicating cre expression was
occurring, and driven by the fhuCBG promoter (C). Sample size for each cre
construct n=3, except for PFhucBG: 'cre (n=1).

Iron Starved Environment

Iron Rich Environment

A

C
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3 .6

The single-copy

P

f iiu c b g

::cre construct does not resolve the loxP cassette in

S. aureus RN6390::/oxP / a7 vitro
Single-copy ere integration vectors were designed utilizing pLL29 (62), a
S. aureus single-copy integration vector based on the lysogenic bacteriophage
L54a and (p11 site-specific recombination systems. The system allows for fast,
reliable chromosomal insertion at two different locations in the S. aureus
genome, based on the location of each bacteriophage’s attB site (62). For the
purposes of this study, the (p11 integration site was selected, as integration at
this site has been shown not to affect the virulence of S. aureus (62). One
problem with the pLL29 vector is that it carries a tetRcassette (Figure 16);
however, this problem was solved by disrupting the tetR cassette with an
erythromycin resistance cassette. This integration vector, pLL29-Ery, was
subsequently used as the backbone for the PFhucBG-'cre and promoterless ere
integration vectors pCM17 and pCM19, respectively. Both vectors were
electroporated into RN4220 and grown overnight on TSB agar containing
erythromycin and lincomycin. Verification of a successful integration was done by
PCR amplifying ere using chromosomal DNA as the template (Data not shown).
The

P fiiucbg: ere

and promoterless ere constructs were then transduced into the

RN6390 and Newman genetic backgrounds; successful transductants were
verified by PCR as previously described in section 3.2 (Data not shown). Figure
17 shows that both the integrated PFhuCBG-'cre and promoterless ere do not
resolve the loxP cassette in both the iron rich and iron starved media, indicating
that ere is not being expressed (or is expressed extremely poorly) from either of
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these strains. Table 6 summarizes the loxP resolution results of both the multi
copy and single-copy ere expression constructs.
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p

Figure 16: Construction of the ere expression integration vectors. The tet
cassette of pLL29 (62) was disrupted using an erythromycin resistance cassette,
ermC, from the pDG646 vector, creating pLL29-Ery. The PFhucBefore
transcriptional fusion and promoterless ere constructs were then cloned into
pLL29-Ery, resulting in pCM17 and pCM19, respectively.
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Figure 17: The integrated ere constructs do not resolve the loxP cassette in the
RN6390: :/oxP strain in vitro in either an iron rich or an iron starved environment.
CFUs were counted over a 12 hour time period in either an iron rich environment
(TSB media; left) or iron starved media (TSB media + 1mM 2, 2-dipyridyl; right)
and plated on agar with or without tetracycline. Both the promoterless ere (A) and
P fiiucbg: ere (B) constructs do not show any evidence of cassette resolution, as
cell growth on plates containing tetracycline was similar to growth seen on plates
with no tetracycline. Sample size, n=3.

Iron Rich Environment

Iron Starved Environment

A

B
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Table 6: loxP cassette resolution after 12 hours in S. aureus RN6390: loxP
Iron rich media
Promoterless ere
(multi-copy)
PFhuCBo::cre
(multi-copy)
P f iiu c b g -

■A1 -27 ere

Integrated
Promoterless ere
Integrated
PFhuCBG::cre

% Excision (SD)
0
84.7
3.4 (+/- 3.9)
17.2 (+/-15.5)
0.4 (+/- 0.8)

Iron starved media
Promoterless ere
(multi-copy)
PFhuCBG::cre
(multi-copy)
PFhuCBG-

■A1 -27 ere

% Excision (SD)
0
99

1.2 (+/-1.1)

Integrated
Promoterless ere

9.5 (+/-16.5)

Integrated
P F h u C B G ” ere

16.7 (+/-16.4)
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Chapter 4: Discussion
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In the last decade, our understanding of S. aureus iron acquisition
systems and their mechanisms of action have increased considerably. Critical
nutrient systems such as these are essential to the survival of the bacteria, and
could play an important role in creating new and innovative methods of treatment
against S. aureus infections. IsdA and IsdH vaccine trials by Clarke et al. have
shown promise in reducing S. aureus nasal carriage in a cotton rat model (20),
while an IsdB vaccine is considered the leading staphylococcal vaccine, and is
currently in human clinical trials (55). Such preventative treatments are of
particular interest in recent years, especially in relation to S. aureus infections.
This is due to the continued rise in not only S. aureus antibiotic resistant strains
such as MRSA, but also in the increased prevalence of antibiotic resistant S.
aureus strains capable of infecting both the immunocompromised and healthy
outside the confines of a hospital. These strains, known as communityassociated Staphylococcus aureus (CA-SA), in addition to having the variety of
iron acquisition systems and virulence determinants found in most S. aureus
strains, have also recently acquired genetic elements which can provide these
strains with a survival advantage in particular environments. A primary example
of this is the arginine catabolic mobile element (ACME). While ACME has been
found in Staphylococcus epidermidis, a known proficient human skin colonizer, it
has recently been identified in most CA-MRSA strains (31). The ACME cassette
has been suggested to increase the proficiency of skin colonization as it contains
the arcABCD loci, which has been shown to be important in arginine catabolism,
allowing for increased survival in acidic environments such as human skin (31).
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The emergence of these CA-SA strains harbouring new genetic elements
makes it more imperative to further elucidate S. aureus-human host interactions.
While extensive in vitro techniques have been developed in order to study and
culture S. aureus, such studies are unable to completely replicate the complexity
of the host environment. Thus, the nature of the host-pathogen interaction,
particularly during the course of an infection, cannot be elucidated using such
techniques alone. In order to study the in vivo environment, a variety of
techniques, dubbed in vivo expression technologies, or IVETs, have been
designed. IVET systems utilize a promoter trap strategy to identify bacterial
promoters that are activated during an infection. A genomic library is built, and
the DNA fragments are fused upstream of a promoterless reporter gene, which is
needed in order for the bacteria to grow normally (or at all) under specific
conditions. To date, four IVET selection variations have been developed:
antibiotic-resistance, auxotrophic, system-specific, and recombination-IVET
(RIVET). Due to its high sensitivity, the RIVET system is of particular interest, as
it is the only IVET variation capable of identifying bacterial genes that are weakly
or transiently expressed during an infection (15); RIVET is also the only IVET
system capable of observing and studying temporal gene expression. This
strategy utilizes the ability of recombinase proteins to bind to specific DNA
sequences that flank at least one reporter gene, resulting in the excision of the
reporter gene(s), and therefore a phenotype which can be screened for.
Recombinase expression is driven only by bacterial DNA fragments with active
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promoters, as these DNA fragments are fused upstream of the recombinase
gene.
The purpose of this study was to build a RIVET based IVET system using
the Cre recombinaselloxP recombination system in order to use it to determine
the temporal expression of iron-regulated S. aureus promoters, first in vitro, then
during infection. While an IVET system has already been developed by Lowe et
al. for S. aureus, the system constructed here would be more robust and allow
for fewer false positives owing to the incorporation of a counter selection marker
in addition to a positive selection marker, an antibiotic resistance cassette. Thus,
the Bacillus subtilis derived levansucrase-encoding sacB was selected as the
counter selection marker for use in this RIVET system. sacB was selected
because it has been used as a counter selective marker in a RIVET system
previously (83) and has been shown to function in S. aureus (30). Thus, sacB
was fused to the constitutive Igt promoter, creating the Pigt sacB construct. This
fusion was used as part of the loxP reporter cassette, consisting of the
aforementioned

sacB fusion, and a tetracycline antibiotic resistance cassette

flanked by two loxP sites. The loxP cassette was integrated into the S. aureus
RN4220 chromosome using a single homologous recombination event and
subsequently transduced to two other strains: RN6390 and Newman.
D’Elia et al. only showed the sacB sucrose sensitivity phenotype in a
single S. aureus strain, RN4220 (30). Thus, it was important to test other S.
aureus strains for a sacB phenotype to see if it could be used as a successful
counter selection marker for the RIVET system. All four strains tested (RN4220,
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RN6390, SH1000, Newman) that had the sacB carrying plasmid pCM6 showed
definitive sucrose sensitivity when the media sucrose concentration was at least
10%. However, this was not the case when the sacB construct was integrated
into the S. aureus chromosome. Of the three strains tested, only the
RN6390::loxP strain showed any sensitivity to sucrose. Thus, a different
approach was used in order to verify the sacB phenotype in each of these
strains. The RN4220::/oxP, RN6390::loxP and Newman::loxP and their
respective wild-type strains were grown in the presence or absence of sucrose in
liquid media over a 48 hour period. Once again, only the RN6390: :loxP strain
showed sensitivity to sucrose. However, the sucrose sensitivity phenotype was
much more obvious from the liquid culture results, as little to no RN6390: :/oxP
growth was observed within the first 16 hours. This was expected, as sacB
induced cell death is believed to be reliant on the continued build up of levan, the
end product of levansucrase fructosyl group polymerization and sucrose
hydrolysis (10). Therefore, as time progresses, levan should continually build up
in the cells, resulting in cell death. Unexpectedly, culture optical density (OD)
began to increase after the 16 hour mark up until the 32 hour mark, at which
point cell growth began to decrease. It is unknown why this increased culture
OD is suddenly seen after 16 hours of incubation; further investigation is required
in order to elucidate these results. The sudden drop in growth after 32 hours
could be attributed to the cells clumping together inside the wells of the bioscreen
plate, resulting in an artificial growth curve drop. This could be verified by
culturing RN6390: loxP cells in liquid media with or without sucrose and plating
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aliquots from either environment over a 48 hour period, and observing cell growth
on each plate.
Once the sacB phenotype was verified in the RN6390 background,
plasmid-based ere constructs were built in order to determine temporal
expression of iron-regulated S. aureus promoters in RN6390::/oxP. The first such
promoter chosen for study was that of fhuCBG, since fhuC is critical to all
characterized iron transport systems in S. aureus (5, 39). As expected, no loxP
cassette resolution was seen in cells carrying either negative controls
(promoterless ere - pCM14; PFhuCBG::creAl-27 - pCM21) after 12 hours in either
the iron rich or iron starved environment. However, resolution of the loxP
cassette was readily apparent with cells harbouring the

P fiiucbg::cre

construct

(pCM15) in both environments. These data indirectly confirm that cassette
resolution is due to ere expression, driven by the fhuCBG promoter. It should be
noted that direct verification of ere expression was attempted using western blot
analysis, however the anti-cre antibody used was not sensitive enough to identify
ere protein (data not shown). Also, while cassette resolution was expected from
cells with pCM15 cultured in an iron starved environment (due to the ironregulated nature of the fhuCBG promoter), cassette resolution in the iron rich
media was not; this can be attributed to a gene dosage effect due to the multi
copy plasmid carrying the

P fiiucbg-•ere

construct. This can result in titration of the

Fur protein, as there is an insufficient amount of Fur in the cell in order to
properly bind to the multi-copy fhuCBG Fur box resulting in an inability to repress
all ere expression. This may also be due to high basal expression levels of
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fhuCBG in the in vitro iron rich environment, and due to the highly sensitive
nature of RIVET, these expression levels result in resolution of the cassette in
the iron rich environment.
In order to eliminate the issue of gene dosage, the promoterless ere and
PFhuCBG'-'ere fusions were integrated into RN6390::/oxP and tested for cassette
resolution. Unfortunately, colonies with the integrated PFhuCBG::cre created no
significant cassette excision, regardless of what media they were cultured in over
a 12 hour time period. This indicates little to no Cre was expressed by the single
copy PFhuCBG^cre construct in the iron starved environment. However, this data
may be skewed due to 2, 2’-dipyridyl, the chelator used to create the iron starved
media. While the CrelloxP system is capable of recombination without any
additional reagents, studies have shown that the presence of Mg2+ in CrelloxP
reactions results in a 25% increase in recombination (2). Therefore, chelation of
Mg2+ from the media may potentially result in a reduction of recombination levels
in the iron starved 2,2’-dipyridyl containing environment. To eliminate this
problem, future in vitro studies should supplement the chelated media with Mg2+,
as this may increase the frequency of cassette resolution. Also, EDDHA might
have been a better choice of chelator for use in this study, as it is unable to enter
the bacterial cell, unlike 2,2’-dipyridyl. Future in vitro studies using CrelloxP using
an iron chelator should take this into account.
While single-copy versions of the ere constructs were used in an attempt
to eliminate potential gene dosage effects as well as reduce the effect of
potentially high basal expression levels of fhuCBG, other strategies can be
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employed to combat these problems. One such strategy requires that the ShineDalgarno sequence of ere be modified so as to reduce ere transcriptional levels,
resulting in less sensitive selection (57); a recent study by Malone et al. observed
the dramatic affects on gene transcription in S. aureus by making slight changes
to the Shine-Dalgarno sequence (67). An additional strategy could involve using
another iron-regulated promoter (preferably one in which basal expression levels
are low) fused to ere, and testing it against the Pfhucbg::ere construct. Such a
construct, a PHtsA-"cre fusion, has been built, however due to time constraints was
not tested.
Future studies using this RIVET system benefit from its versatility. Both
reporter genes of the loxP cassette can easily be replaced by other reporter
genes, given the modular nature of the cassette. The loxP cassette also
contains two unique restriction sites (Sma\ and Xho\) that can be used to
incorporate additional reporter genes. One potential reporter gene that could be
implemented into this cassette would be that of a fluorescent gene; recent
studies have generated codon-optimized cyan-, yellow- and red fluorescent
proteins for S. aureus (67, 98). The addition of a fluorescent gene would provide
an additional screen for identifying individual cells in which the loxP cassette has
been excised.
Due to its versatility, a variety of future experiments can be performed
using this RIVET system. The most prominent of these experiments would be
the identification of ivi genes using this system in combination with a genomic
DNA library. Bacterial DNA fragments can be fused upstream of ere, and
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subsequently be screened to first eliminate promoters activated in vitro. Those
fragments that remain inactive in vitro can then be passaged through a variety of
hosts, and ivi genes can then be identified by screening for a specific phenotype.
DNA fragments containing active promoters of unknown function can then be
sequenced and characterized. The RIVET system could also be used to develop
experiments to determine the temporal expression of specific ivi genes over the
course of an infection. Such experiments can not only identify potential new
virulence determinants, but can also be used to further elucidate host-S. aureus
interactions through the analysis of when select genes are turned on over the
course of an infection.
This thesis describes the construction of what could become a potent and
versatile RIVET system that has been successfully shown to work in S. aureus in
vitro. This system has considerable potential to identify in vitro as well as ivi
genes expressed in a variety of environments. It can also be used to study
temporal expression of ivi genes over the course of an infection. Such studies
could significantly add to our understanding of how S. aureus interacts with its
host in vivo, as well as aiding in the development of new therapeutic treatments
against S. aureus infections.
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